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We have evaluated the binding of sialylated and desialylated lipoproteins to collagen isolated from the proteoglycan and
musculoelastic layers of intima and media of uninvolved human aorta and atherosclerotic lesions. Comparing various collagen
preparations from the uninvolved intima-media, the binding of sialylated apoB-containing lipoproteins was best to collagen
from the intimal PG-rich layer. Binding of sialylated apoB-containing lipoproteins to collagen from this layer of fatty streak and
ﬁbroatheroma was 1.4- and 3.1-fold lower, respectively, in comparison with normal intima. Desialylated VLDL versus sialylated
one exhibited a greater binding (1.4- to 3.0-fold) to all the collagen preparations examined. Desialylated IDL and LDL showed a
higher binding than sialylated ones when collagen from the intimal layers of ﬁbroatheroma was used. Binding of desialylated HDL
to collagen from the intimal PG-rich layer of normal tissue, initial lesion, and fatty streak was 1.2- to 2.0-fold higher compared
with sialylated HDL.
1.Introduction
Deposition of extracellular lipids on the components of the
connective tissue matrix is one of the earliest and most pro-
nounced manifestations of atherosclerotic lesion in human
vessels. At present, data are available for the interaction of li-
poproteins, above all of low-density lipoprotein (LDL), with
elastin and proteoglycans (PGs) of the vessel wall [1–4].
Another main component of the extracellular matrix is col-
lagen [5–7]. Although its role in the structural organization
of the vascular wall and platelet aggregation has been con-
clusively demonstrated [8, 9], little is known concerning its
interaction with blood lipoproteins that enter the arterial
intima or its involvement in extracellular lipid accumulation
in atherosclerotic arteries. Many investigators have reported
a rise in the total collagen level in atherosclerotic lesions [10–
12]. However, the data concerning the changes of collagen
composition in the arterial intima during atherogenesis are
contradictory [13–16]. In a number of other studies, LDL
binding to diﬀerent collagen types was examined [17–20].
Most of these studies included the use of collagen isolated
from collagen-rich tissues of animals. Binding of LDL and
other human blood lipoproteins to collagen isolated from
variouslayersofthenormalandatherosclerotichumanaorta
has not been studied so far.
Earlier, we identiﬁed circulating multiple-modiﬁed LDL.
Unlike native LDL, modiﬁed LDL induced an accumulation
of cholesterol and cholesteryl esters in smooth muscle cells2 Journal of Lipids
cultured from the uninvolved human aortic intima [21–
23]. The major characteristic feature of modiﬁed LDL was
a low content of sialic acid, the terminal carbohydrate of the
biantennary sugar chains in apoB and carbohydrate chains
in gangliosides [24]. This property allowed us to develop a
method for isolating desialylated particles from the total li-
poprotein fraction using lectin chromatography on Ricinus
communis agglutinin (RCA120) agarose. Modiﬁed, desialy-
lated LDL was also characterized by a low level of neutral
lipids, decreased content of phospholipids and fat-soluble
vitamins, smaller size, higher density, increased electroneg-
ative charge, and altered tertiary apolipoprotein structure.
Recently, using lectin chromatography, we have determined
the presence of desialylated subfractions of very-low-density
lipoprotein (VLDL) and intermediate-density lipoprotein
(IDL) in human blood. Like desialylated LDL, desialylated
VLDL and IDL induced cholesterol accumulation in the cells
of unaﬀected human aortic intima. In this study, we have
performedaquantitativecomparativeanalysisofthebinding
of sialylated and desialylated VLDL, IDL, LDL, and high-
density lipoprotein (HDL) to collagen isolated from two lay-
ers of the intima and the media taken from normal regions,
initial lesions, fatty streaks, and ﬁbroatheromas of human
aorta.
2.MaterialsandMethods
2.1. Isolation of Collagen. Seven human thoracic aortas from
men aged 35–55 years were taken aseptically within 1 to 3h
after sudden death from myocardial infarction. After me-
chanicalseparationoftheadventitia,vesselswereincisedlon-
gitudinally, and the type of atherosclerotic lesion was deter-
mined according to the classiﬁcation suggested by Stary [25].
Tissue of each type (normal or aﬀected) was pooled. Intima
was separated from media and divided mechanically into
proteoglycan- (PG-) rich (elastic-hyperplastic) and muscu-
loelastic layers.The accuracyofthe procedure wasveriﬁed by
lightmicroscopy[26].Thecollagenwasextractedfromaortic
tissue samples (0.2–2.5g) using the Lansing procedure [27]
modiﬁed by Noma et al. [1] and delipidated three times with
chloroform/methanol (2:1, v/v), two times with acetone
and then once with diethyl ether. A suspension of collagen
(500μg/mL in PBS, pH = 7.2) was obtained by sonication
in an ice-water bath for ten repetitive cycles for an overall
period of 15 minutes.
2.2. Isolation of Lipoproteins. Blood was drawn from the
ulnar vein of healthy subjects and patients with coronary
atherosclerosis into plastic tubes containing EDTA (1mg/mL
blood). Blood cells were removed by two-step centrifugation
at 3000rpm for 10min. Total VLDL, IDL, LDL, and HDL
fractions were isolated by ultracentrifugation as described
earlier [17]. Lipoproteins were dialyzed against 3 × 2000
volumes of 50mM Tris-HCl, pH7.0 at 4◦C overnight, and
sterilized by ﬁltration (0.45μm). Lectin chromatography
on Ricinus communis agglutinin (RCA120; Boehringer Man-
nheim GmbH, Mannheim, Germany) bound to agarose was
used to separate the sialylated and desialylated lipoproteins
[16]. Sialylated and desialylated VLDL, IDL, and LDL were
iodinated according to Bilheimer et al. [28]. The speciﬁc
activity of 125I-lipoprotein ranged from 55 to 250cpm/ng
protein. Sialylated and desialylated HDL was iodinated (42–
102cpm/ng protein) according to Markwell [29].
Sialylated lipoproteins were treated with 0.02U/mL
neuraminidase from Arthrobacter ureafaciens (Oxford Gly-
coSystems, Oxford, UK) at 37◦Cf o r6h .
2.3. Binding Studies. 96-well microtiter plates (Nunc, Ros-
kilde, Denmark) were coated with 100μLc o l l a g e np e rw e l l
at concentrations of 1–10μg/mL in PBS, pH = 7.2 by in-
cubation at 4◦C for 24h. The wells were washed four times
with PBS containing 0.05% Tween-20, and 100μL of PBS
containing 2% bovine serum albumin (PBS-BSA) was added
to the wells to block remaining nonspeciﬁc binding sites.
After reaction at 20◦C for 1h, the wells were washed with
PBS-BSA, and 100μL per well of iodinated lipoprotein (1–
60μg protein/mL) was added and incubated at 37◦Cf o r
1–3h. Following incubation, the plates were washed with
PBS-BSA. Bound iodinated lipoprotein was released with
200μL of 0.1N NaOH, and radioactivity was measured with
RackGammaIIgammacounter(WallacOY,Turku,Finland).
2.4. Statistical Analysis. The signiﬁcance of diﬀerences be-
tween group mean values was evaluated using a BMDP sta-
tistical program package [30].
3. Results
3.1. Binding of Sialylated and Desialylated VLDL to Collagen.
Preliminary experiments showed that the binding of both
sialylated and desialylated VLDL to collagen isolated from
various layers of the uninvolved aortic intima-media did not
depend on collagen concentration, used for coating the wells
of microtiter plates, in the range of 1–10μg/mL (data not
shown). Concentration curves and time curves of VLDL
binding were linear over the lipoprotein concentration range
of 1–30μg protein/mL and within a period of 1–3h (not
shown). Similar results were obtained with other lipopro-
teins. In all subsequent experiments, collagen concentration
in the coating solution was 2μg/mL and lipoproteins were
incubated in the collagen-coated wells at the concentration
of 10μg protein/mL for 2h.
Table 1 shows the data obtained with VLDL. Sialylated
VLDL bound at a similar extent to collagen from the intimal
PG-rich layer of uninvolved area and that of initial lesion.
The amount of sialylated VLDL binding to collagen from the
fatty streak and ﬁbroatheroma was 3.1- and 2.3-fold lower,
respectively, in comparison with normal tissue.
Between the two collagens of the uninvolved intima,
2.9-fold less sialylated VLDL was bound to collagen from
the musculoelastic layer. The binding capacity for sialylated
VLDL of collagen from the musculoelastic layer did not
depend on the stage of lesion progression and was the same
with normal and diseased tissue.
In a similar manner, collagen of media, regardless of
whether it was isolated from the areas under unlesioned in-
tima, initial lesions, fatty streaks, or ﬁbroatheromas, had an
identical binding capacity for sialylated VLDL. In addition,Journal of Lipids 3
Table 1: Binding of sialylated and desialylated VLDL to collagen
isolated from two layers of the intima and the media of uninvolved
and atherosclerotic areas of human aorta.
Lipoprotein
Collagen-bound apoB, pg/well
PG-rich layer Musculoelastic
layer Media
Uninvolved area
Sialylated VLDL 414 ± 37 143 ± 10 150 ± 4∗
Desialylated
VLDL 650 ± 58∗ 299 ± 20∗ 328 ± 4
Initial lesion
Sialylated VLDL 435 ± 10 126 ± 10 120 ± 12∗
Desialylated
VLDL 598 ± 18∗ 310 ± 20∗ 304 ± 15
Fatty streak
Sialylated VLDL 135 ± 11& 113 ± 10 130 ± 7
Desialylated
VLDL 233 ± 10∗& 339 ± 10∗ 332 ± 8∗
Fibroatheroma
Sialylated VLDL 180 ± 12& 127 ± 3 165 ± 4
Desialylated
VLDL 383 ± 20∗& 336 ± 30∗ 440 ± 9∗
Each well of 96-well microtiter plates was coated with collagen and washed
as described in Section 2. The binding of VLDL (10μg/mL) was performed
at37◦Cf o r2h.V al uesar ethemeans±S.E.M(n =4); ∗signiﬁcantdiﬀerence
from sialylated VLDL (P<0.05); &signiﬁcant diﬀerence from uninvolved
region (P<0.05).
the extent of sialylated VLDL binding to collagen from the
media was the same as to collagen from the musculoelastic
layer of the intima.
With all collagen preparations, desialylated VLDL exhib-
ited greater binding than did sialylated VLDL: the amount
of bound desialylated VLDL was 1.4- to 3.0-fold above the
amount of bound sialylated one.
3.2. Binding of Sialylated and Desialylated IDL to Collagen.
Table 2 summarizes the results obtained with IDL. Sialylated
IDL showed similar binding to collagen from the PG-rich
layer of normal intima and that of the initial lesion. The
binding of sialylated IDL to collagen from this layer of fatty
streak and of ﬁbroatheroma was 2.4- and 1.6-fold lower,
respectively, compared with uninvolved areas.
We did not ﬁnd any signiﬁcant diﬀerence in binding of
sialylated IDL by collagen between the intimal musculoelas-
tic layer and medial layer, or between normal and aﬀected
regions of these layers.
When extracted from the PG-rich or musculoelastic
layer of uninvolved intima, an initial lesion, or the fatty
streak, collagen bound desialylated and sialylated IDL to a
similar extent; however, when isolated from these layers of
ﬁbroatheroma, it exhibited an increased (1.3-fold) binding
capacity for desialylated IDL. No signiﬁcant diﬀerence in
binding to collagen from the media underlying normal
intima, initial lesions, fatty streaks, or ﬁbroatheroma was
observed between desialylated and sialylated IDL.
Table 2: Binding of sialylated and desialylated IDL to collagen
isolated from two layers of the intima and the media of uninvolved
and atherosclerotic areas of human aorta.
Lipoprotein
Collagen-bound apoB, pg/well
PG-rich layer Musculoelastic
layer Media
Uninvolved area
Sialylated IDL 512 ± 21 325 ± 27 385 ± 27
Desialylated IDL 559 ± 61 393 ± 12 418 ± 19
Initial lesion
Sialylated IDL 547 ± 27 270 ± 32 237 ± 19
Desialylated IDL 554 ± 18 287 ± 19 229 ± 7
Fatty streak
Sialylated IDL 214 ± 4& 236 ± 6 234 ± 14
Desialylated IDL 243 ± 17& 296 ± 13 258 ± 14
Fibroatheroma
Sialylated IDL 331 ± 18& 187 ± 16 260 ± 18
Desialylated IDL 419 ± 19∗& 238 ± 2∗ 276 ± 12
Each well of 96-well microtiter plates was coated with collagen and washed
as described in Section 2. The binding of IDL (10μg/mL) was performed at
37oCf o r2h .V a l u e sa r et h em e a n s± S.E.M (n = 4); ∗signiﬁcant diﬀerence
from sialylated IDL (P<0.05); &signiﬁcant diﬀerence from uninvolved
region (P<0.05).
3.3. Binding of Sialylated and Desialylated LDL to Collagen.
Table 3 liststheresultsforLDL.Thebindingtocollagenfrom
the PG-rich layer of the uninvolved intima appeared to be
similar among sialylated LDL, IDL, and VLDL.
1.4- to 1.8-fold less sialylated LDL bound to collagen
from the PG-rich layer of initial lesion, fatty streak, and ﬁ-
broatheroma compared with the PG-rich layer of uninvolved
intima.
ThebindingcapacityforsialylatedLDLdidnotdiﬀersig-
niﬁcantly among collagens from the intimal musculoelastic
layer and the media of all tested tissue types.
Desialylated and sialylated LDL showed similar binding
toeachofthecollagensisolatedfromuninvolvedregions,ini-
tial lesions, and fatty streaks. However, with ﬁbroatheroma,
we found a better binding of desialylated LDL: its amount
bound to collagen from the PG-rich and musculoelastic
layers was 1.2- and 1.4-fold greater, respectively, than the
amount of bound sialylated LDL.
3.4. Binding of Sialylated and Desialylated HDL to Collagen.
As seen from the data presented in Table 4, there was no
statistically signiﬁcant diﬀerence in binding of sialylated
HDL to the collagens isolated from both the intimal layers
and media taken from areas of uninvolved tissue, initial
lesions,andthefattystreak.Whencollagenwasisolatedfrom
theintimallayersofﬁbroatheromaandthemediaunderlying
the ﬁbroatheroma, it bound 1.4- to 1.8-fold more sialylated
HDL compared with collagen of normal tissue.
Desialylated HDL bound to collagen from the intimal
PG-richlayerofuninvolvedareas,initiallesions,andthefatty
streak better than sialylated HDL. On the contrary, the bind-
ing of desialylated versus sialylated HDL was 2-fold lower4 Journal of Lipids
Table 3: Binding of sialylated and desialylated LDL to collagen
isolated from two layers of the intima and the media of uninvolved
and atherosclerotic areas of human aorta.
Lipoprotein
Collagen-bound apoB, pg/well
PG-rich layer Musculoelastic
layer Media
Uninvolved area
Sialylated LDL 507 ± 27 331 ± 8 408 ± 13
Desialylated
LDL 416 ± 47 350 ± 10 353 ± 15
Initial lesion
Sialylated LDL 363 ± 18& 373 ± 12 426 ± 14
Desialylated
LDL 374 ± 14 374 ± 7 517 ± 7
Fatty streak
Sialylated LDL 277 ± 5& 332 ± 26 356 ± 17
Desialylated
LDL 290 ± 5 317 ± 17 403 ± 12
Fibroatheroma
Sialylated LDL 460 ± 11& 365 ± 13 458 ± 15
Desialylated
LDL 539 ± 16∗ 508 ± 13∗ 527 ± 15
Each well of 96-well microtiter plates was coated with collagen and washed
as described in Section 2. The binding of LDL (10μg/mL) was performed at
37◦Cf o r2h .V a l u e sa r et h em e a n s± S.E.M (n = 4); ∗signiﬁcant diﬀerence
from sialylated LDL (P<0.05); &signiﬁcant diﬀerence from uninvolved
region (P<0.05).
whencollagenfromthemediaunderlyingﬁbroatheromawas
used. No signiﬁcant diﬀerence was seen between sialylated
and desialylated HDL with the respect to their binding to
collagen from the musculoelastic layer of nonatheroslerotic
or atherosclerotic intima.
3 . 5 .T h eI n ﬂ u e n c eo fS i a l i cA c i dR e m o v a lo nL i p o p r o t e i nB i n d -
ing to Collagen. Neuraminidase was used to remove sialic
acid from sialylated lipoprotein. Neuraminidase treatment
reduced the sialic acid content of lipoproteins by 60–73%
compared with untreated controls. A comparative analysis
between sialylated and chemically desialylated samples was
performed by measuring lipoprotein binding to collagen
from the intimal PG-rich layer of uninvolved areas and
ﬁbroatheroma. The results are presented in Table 5.
Treatment of native (sialylated) VLDL, IDL, and LDL
had no eﬀect on their binding to collagen from the intimal
PG-rich layer when the latter was taken from uninvolved
areas. However, the binding of neuraminidase-treated apoB-
containing lipoproteins to collagen from the intimal PG-
rich layer of ﬁbroatheroma was found to be 1.8- to 3.5-fold
higher than that of native lipoproteins. Thus, a loss of sialic
acid stimulated binding of apoB-containing lipoproteins to
collagen from lesioned regions, but not from uninvolved
tissue.
No diﬀerence in binding to collagen isolated either from
uninvolvedintimaorfromﬁbroatheromasappearedbetween
the treated and untreated HDL.
Table 4: Binding of sialylated and desialylated HDL to collagen
isolated from two layers of the intima and the media of uninvolved
and atherosclerotic areas of human aorta.
Lipoprotein
Collagen-bound apoA1, pg/well
PG-rich layer Musculoelastic
layer Media
Uninvolved area
Sialylated HDL 279 ± 4 312 ± 12 274 ± 50
Desialylated
HDL 320 ± 3∗ 319 ± 3 276 ± 13
Initial lesion
Sialylated HDL 256 ± 15 299 ± 14 369 ± 16
Desialylated
HDL 524 ± 34&∗ 280 ± 9 378 ± 13
Fatty streak
Sialylated HDL 256 ± 27 313 ± 17 320 ± 43
Desialylated
HDL 431 ± 26&∗ 290 ± 17 310 ± 16
Fibroatheroma
Sialylated HDL 382 ± 36& 500 ± 18& 497 ± 15&
Desialylated
HDL 290 ± 12 508 ± 14& 242 ± 17∗
Each well of 96-well microtiter plates was coated with collagen and washed
as described in Section 2. The binding of HDL (10μg/mL) was performed at
37◦Cf o r2h .V a l u e sa r et h em e a n s± S.E.M (n = 4); ∗signiﬁcant diﬀerence
from sialylated HDL (P<0.05); &signiﬁcant diﬀerence from uninvolved
region (P<0.05).
4. Discussion
The present results show that circulating lipoproteins can
bind to collagens isolated from the PG-rich and musculoe-
lastic layers of the intima and the media of uninvolved and
atherosclerotic regions of the human aorta. The novelty of
ﬁndings evolves from comparative evaluation of the bind-
ingofsialylated(native)anddesialylated(modiﬁed)lipopro-
teins (VLDL, LDL, LDL, and HDL) to collagen. We have
demonstrated that the binding of sialylated (native) apoB-
containing lipoproteins was best to collagen from the intimal
PG-rich layer. However, the binding of sialylated apoB-
containing lipoproteins to collagen from PG-rich layer of
fatty streak and ﬁbroatheroma was 1.4- and 3.1-fold lower,
respectively, in comparison with normal intima. Desialylated
(modiﬁed) VLDL versus sialylated one exhibited a greater
binding (1.4- to 3.0-fold) to all the collagen preparations
examined; desialylated (modiﬁed) IDL and LDL also showed
a higher binding than sialylated ones when collagen from the
intimal layers of ﬁbroatheroma was used. Binding of desial-
ylated (modiﬁed) HDL to collagen from the intimal PG-rich
layer of normal tissue, initial lesion, and fatty streak was 1.2-
to 2.0-fold higher compared with sialylated (native) HDL.
These ﬁndings clearly demonstrate that at least two variables
(lipoprotein modiﬁcation and the type of atherosclerotic
lesion) play the decisive role in the eﬃcacy of lipoprotein
binding to collagen.
Of the two collagens of the uninvolved intima-media, the
one with the highest binding capacity for apoB-containingJournal of Lipids 5
Table 5: Eﬀect of neuraminidase treatment on lipoprotein sialic acid content and lipoprotein binding to collagen.
Lipoprotein Sialic acid content, % of
control
Binding to collagen from the PG-rich
l a y e ro fn o r m a li n t i m a ,%o fc o n t r o l
Binding to collagen from the PG-rich
l a y e ro fﬁ b r o a t h e r o m a ,%o fc o n t r o l
VLDL 40 ± 3∗ 107 ± 6 178 ± 11∗
IDL 28 ± 3∗ 117 ± 9 214 ± 12∗
LDL 27 ± 2∗ 108 ± 10 347 ± 21∗
HDL 36 ± 3∗ 114 ± 8 117 ± 9
Sialylated lipoproteins were treated with 0.02U/mL neuraminidase from Arthrobacter ureafaciens at 37◦C for 6h. Control lipoproteins were incubated in the
absenceofneuraminidase.Lipoproteinswerethenreisolatedbyultracentrifugation,andmicrotiterwellbindingassaywasperformedasdescribedinSection 2.
Values are the means ± S.E.M (n = 4); ∗signiﬁcant diﬀerence from control (P<0.05).
lipoproteins was collagen from the intimal PG-rich layer. In
the case of an initial lesion, collagen from this layer also
showedahigherbindingactivity,butonlyforVLDLandIDL.
Thesedataindicatethat,inthehumanaorticintima,collagen
ofthePG-richlayerandthemusculoelasticlayerarediﬀerent
in their lipoprotein-binding properties. Unfortunately, we
failed to ﬁnd published information on the collagen compo-
sition of the distinct layers of the human arterial intima.
VLDL, IDL, and LDL bound less to collagen from the
intimal PG-rich layer of the fatty streak and ﬁbroatheroma
than to collagen from the respective layer of uninvolved inti-
ma. In addition, LDL revealed a lower binding to collagen
from this layer of an initial lesion compared with normal
intima. In the human arterial wall, the alterations related to
atherosclerosis are mainly conﬁned to the PG-rich layer of
the intima. It is not surprising, therefore, that, in our study,
collagen isolated just from this layer exhibited varying bind-
ing activity for apoB-containing lipoproteins, depending on
which tissue, normal or lesioned, was taken and the stage of
lesion development.
A decreased binding of apoB-containing lipoproteins to
collagen from the atherosclerotic intima may reﬂect disease-
related changes in collagen composition of the aortic tissue.
It was shown earlier that the main collagens in human aortas
weretype I and type III [31–35]. Data on the relative content
ofthesecollagenphenotypesarecontradictory.Ononehand,
McCullagh and Balian reported that collagen type I, which
was low in comparison to type III in normal aortas, exceeded
type III in atherosclerotic aortas [33]. On the other hand,
some other investigators showed that in uninvolved, as well
as atherosclerotic, aortas, most of the collagen was of type I
[15,36–38].Thesediscrepancies,probably,maybeattributed
to variations in material and/or procedures for the isolation
of collagen. For example, type III collagen is known to be
extracted by pepsin more readily than type I collagen [39].
However, despite contradictions in regard to the percentage
of collagen types in unaﬀected human aortic intima, all au-
thors note that type I collagen increases in atherosclerosis,
whereas type III collagen decreases [15, 35, 37, 40]. As for
the total collagen, its level is by far elevated in atherosclerotic
lesions [15, 35].
Human aortas have been shown to contain, besides col-
lagen types I and III, also collagen type V [36, 37, 41].
MortonandBarnes[37]andM urataetal.[15]foundthatthe
amount of collagen type V in human aortas was comparable
with that of collagen type III and constituted 15–20% of
collagen type I. In addition, it was demonstrated that the
share of type V collagen was 2-fold higher in atherosclerotic
aortas than in normal aortas [15, 37]. The human aortas also
contain small amounts of collagen types IV and VI [15, 31,
42]. Murata et al. found a considerable increase in type IV
collageninatheroscleroticlesions[15]:itscontentwasshown
to be 6- to 7-fold higher compared with type VI.
Although there are variations, a conclusion from the
discussed data is that the relative contents of collagen types
IV and V are increased in atherosclerotic aorta, while those
ofcollagentypesIandIIIaredecreased.Usingaradioisotope
method, Greilberger J. et al. found that the binding activities
for oxidized LDL followed the order: type I > type V and
typeIII>typeIVcollagen[20]. Therefore,the collagentypes
that decrease in atherosclerotic lesions are those which can
bindLDLwell,andthetypesthatincreasehavealowbinding
activity for LDL. In light of these considerations, and taking
into account the fact that the collagen preparations, used
in our study, included total collagen, we may suppose that
disease-related changes in the collagen composition account
for a decreased binding of apoB-containing lipoproteins to
collagen from the PG-rich layer of the atherosclerotic intima.
The pattern of HDL binding to various collagen prepara-
tions diﬀered from the pattern for apoB-containing lipopro-
teins. The amount of bound HDL was similar in all three
collagen preparations from the uninvolved intima-media,
and the level of binding did not change when initial lesions
or fatty streaks, instead of uninvolved regions, were used for
the isolation of collagen. Binding, however, was increased
when collagen from the PG-rich and musculoelastic layers of
ﬁbroatheroma or the media underlying ﬁbroatheroma was
used.
Compared to sialylated VLDL, in vivo desialylated VLDL
exhibited better binding to all types of collagen preparations
examined. In vivo desialylated IDL and LDL bound to col-
lagen to a greater extent than sialylated ones if the collagen
was isolated from the PG-rich or musculoelastic layers of
ﬁbroatheroma. These data imply that the diﬀerence in bind-
ing to collagen between VLDL and other apoB-containing
lipoproteins is not associated solely with sialic acid level.
This is conﬁrmed by the results obtained with chemically
desialylatedlipoproteins.Partialdesialylationofnative,sialy-
lated lipoproteins was achieved by neuraminidase treatment.
The apoB-containing lipoproteins devoid of a part of sialic
acid showed an increased ability to bind to collagen from
the PG-rich layer of ﬁbroatheroma, but not of uninvolved6 Journal of Lipids
intima. Thus, sialic acid removal and a concomitant change
in the lipoprotein surface charge do not aﬀect the binding of
lipoproteins, including VLDL, to collagen of normal intimal
tissue. We have previously shown that desialylated VLDL
compared with sialylated VLDL has markedly reduced levels
of neutral lipids and phospholipids (Tertov, in preparation).
Therefore, we may assume that just a loss of lipids favors the
binding of desialylated VLDL to collagen of normal aortic
tissue. This assumption is in agreement with the current
observation that the binding of sialylated apoB-containing
lipoproteins to collagen from the PG-rich layer of normal
intima decreases in the direction from LDL to IDL to VLDL,
that is, as the lipid/protein ratio increases. It is thus possible
thatthisrelativelylowlevelofsialylatedVLDLbindingresults
from masking the collagen-binding loci by lipids.
IDL and LDL showed an increase in their binding to
collagen from the intimal PG-rich layer of ﬁbroatheroma
after neuraminidase treatment. As mentioned above, a ﬁ-
broatheroma is characterized by signiﬁcant changes in the
collagen composition and collagen properties as compared
to the unaﬀected intima. Apparently, an eﬃcient interaction
between neuraminidase-treated apoB-containing lipopro-
teins and collagen of ﬁbroatheroma may be related largely
to these changes. Thus, a fall in the sialic acid content may be
one of the factors that promote binding desialylated apoB-
containing lipoproteins to collagen of atherosclerotic lesions.
One more factor that may contribute to the binding of de-
sialylated lipoproteins to collagen is their increased elec-
tronegative surface charge.
As we have earlier shown, desialylated LDL, isolated
from the total LDL fraction, has an increased electronegative
charge relative to sialylated LDL. One may expect that a loss
of sialic acid makes the surface charge of a lipoprotein par-
ticle more positive. However, as follows from our previous
studies, desialylated LDL may be referred to as multiple-
modiﬁed lipoproteins since they diﬀer from native lipopro-
teins by a number of alterations, including the modiﬁed
lysineresiduesandmodiﬁedtertiarystructureofapolipopro-
tein. These modiﬁcations increase the negative charge of the
apolipoprotein surface. The importance of negative surface
charge in the interaction of LDL with collagen was indicated
earlier by observations that collagen bound oxidized LDL,
w h o s en e g a t i v ec h a r g ei si n c r e a s e d ,m o r ee ﬃciently. For ex-
ample, Hoover et al. [18], by using a gel diﬀusion technique,
demonstrated that oxidatively modiﬁed 125I-LDL bound
better to collagen than nonoxidized 125I-LDL, and the
amount of binding depended on the extent of modiﬁcation.
Based on these results, the authors have assumed that a net
negative surface charge of lipoproteins is the determining
factor for their binding to collagen. This assumption was
later supported by others. Greilberger et al. [20] showed
that HDL3, native and oxidized with CuSO4, could bind to
collagen types I and III and that 2h-oxidized HDL3,w h i c h
had the highest negative charge had the highest binding
activity. Chen et al. [43] also showed that oxidized LDL
interacted more eﬃciently with collagen compared to native
LDL, and increasing the negative charge in oxidized LDL was
associated with progressively greater increases in binding to
collagen. The enhanced binding of desialylated lipoproteins
to collagen may be explained in part by the presence of a
greater negative charge on the surface of desialylated lipo-
protein particle.
The inﬂuence of neuraminidase treatment of HDL on
binding to collagen from the PG-rich layer was observed nei-
ther when this layer was taken from uninvolved intima nor
when it was taken from ﬁbroatheroma. Hence, sialic acid
seemstobeunessentialforHDLbindingtocollagen.Agreat-
er binding of desialylated HDL versus sialylated HDL, seen
withcollagenfromthePG-richlayerofnormalintima,initial
lesions,andfattystreaks,isprobablyduetoanincreaseinthe
electronegativesurfacechargeindesialylatedlipoprotein,but
not to a loss of sialic acid.
The present study has demonstrated that collagen from
variouslayersofunaﬀectedandatherosclerotichumanaortic
intima-media is capable of binding diﬀerent fractions of
human blood lipoproteins. In vivo, this binding may con-
tribute to extracellular lipid accumulation. Further studies
on the interaction of native and modiﬁed lipoproteins with
diﬀerent types of collagen from human aortas should estab-
lish mechanisms of this interaction and ways to regulate this
process.
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